[1]
Albuquerque, L.M.V. de et al. 2026. 547 - EVALUATION OF PATHOLOGIC COMPLETE RESPONSE, DISEASE-FREE SURVIVAL, AND GLOBAL SURVIVAL OF PATIENTS WITH BREAST CANCER, TRIPLE-NEGATIVE SUBTYPE, WHO UNDERWENT PLATINUM-BASED NEOADJUVANT CHEMOTHERAPY AT HOSPITAL DE CÂNCER DE PERNAMBUCO IN 2018–2021. Mastology. 32, suppl.1 (Mar. 2026). DOI:https://doi.org/10.29289/259453942022V32S1006.